Hot Stocks: salesforce.com (NYSE:CRM), Boston Properties (NYSE:BXP), Micronet Enertec Technologies (NASDAQ:MICT), Bio-Rad Laboratories (NYSE:BIO)

Salesforce.com, Inc. (NYSE:CRM) is a cloud software company that is planning to expand its San Francisco headquarters by more than 700,000 square feet by taking a 15.5-year lease on a 61-story office story building that is under construction. Salesforce.com is going to lease over half of the building, which will be located at: 415 Mission Street. Part of the HQ will be called Salesforce Tower. salesforce.com, inc. (NYSE:CRM) shares after opening at $53.82 moved to $54.50 on last trade day and at the end of the day closed at $52.87. Company price to sales ratio in past twelve months was calculated as 7.92 and price to cash ratio as 38.46. salesforce.com, inc. (NYSE:CRM) showed a negative weekly performance of -2.83%.

Boston Properties, Inc. (NYSE:BXP) A real estate investment trust, and its development partner Hines said they have signed a lease with salesforce.com for 714,000 square feet of space in an office tower under construction in San Francisco. Boston Properties, Inc. (NYSE:BXP) shares advanced 0.79% in last trading session and ended the day on $115.35. BXP return on equity ratio is recorded as 14.70% and its return on assets is 4.20%. Boston Properties, Inc. (NYSE:BXP) yearly performance is 9.50%.

Micronet Enertec Technologies, Inc. (NASDAQCM: MICT), announced over $400,000 in orders for its A307 mobile computing device from new MRM customers.Micronet Enertec Technologies Inc (NASDAQ:MICT) shares moved up 0.46% in last trading session and was closed at $4.35, while trading in range of $4.35-$4.37. Micronet Enertec Technologies Inc (NASDAQ:MICT) year to date performance is -14.71%.

GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, announced that it was acquired by Bio-Rad Laboratories, Inc. (NYSE:BIO) With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts. Bio-Rad Laboratories, Inc. (NYSE:BIO) weekly performance is -5.08%. On last trading day company shares ended up $120.08. Bio-Rad Laboratories, Inc. (NYSE:BIO) distance from 50-day simple moving average is -6.48%. Analysts mean target price for the company is $140.50.